Category: Worldwide collaboration

Next Meats Launches “Next Meats Accelerator Program” to Initiate Global Collaboration in Alternative Protein Industry

TOKYO, March 3, 2021 / PRNewswire / – Japanese alternative meat company Next Meats Co., Ltd. (Tokyo, CEO: Hideyuki Sasaki) has just announced the launch of the “Next Meats Accelerator Program”, which offers and serves as a platform to drive global open innovation among players in the alternative protein industry as well as all individuals […]

Artiva Biotherapeutics Announces Exclusive Global Collaboration and License Agreement with Merck to Develop Candidate CAR-NK Cell Therapies

Collaboration uses Artiva’s proprietary allogeneic NK and CAR technology platforms to develop up to three CAR-NK cell therapies targeting solid antigens associated with tumors Artiva will receive an upfront payment of $ 30 million and up to $ 612 million per program in potential future development and commercial milestones, as well as royalties on any […]

ACI’s Global Collaboration with Hi-Pay is a Growth Catalyst for Mongolia’s Emerging Payments Ecosystem

NAPLES, Florida – (COMMERCIAL THREAD) – ACI Worldwide (NASDAQ: ACIW), a leading global provider of real-time electronic payment and banking solutions, today announced that High Payment Solutions LLC (Hi-Pay) has successfully launched its new payment hub using multiple ACI solutions to create Mongolia’s first payment gateway service. ACI’s technology gives Hi-Pay a fundamental platform on […]

Other Half Brewing Announces Global Collaboration with All Together Beer to Benefit Hospitality Industry

BROOKLYN, NY – – The Other Half Brewing Co team is proud to announce All Together, a global beer collaboration created to raise funds and raise awareness of the industry we love so much. Regardless of the location or the circumstances, when a member of the hospitality industry is struggling, the rest of the group […]

Rheos Medicines Announces Global Collaboration with Roche to Discover and Develop New Medicines in the Field of Immunometabolism

CAMBRIDGE, Mass .– (COMMERCIAL THREAD) – Rheos Medicines (Rheos), a biopharmaceutical company that harnesses knowledge in immunometabolism to create a new therapeutic class for patients with severe autoimmune disorders, inflammatory diseases and cancer, today announced that it has entered into a worldwide exclusive collaboration, option and license agreement with Roche to discover, develop and commercialize […]

Parvus Therapeutics enters global collaboration and licensing agreement with Genentech to develop Navacim ™ Therapeutics for the treatment of autoimmune diseases

BURLINGAME, Calif. And CALGARY, Alberta – (COMMERCIAL THREAD) – Parvus Therapeutics, a biopharmaceutical company focused on the development of disease-specific immunoregulatory drugs to treat autoimmune diseases without altering normal immunity, has entered into a global collaboration and licensing agreement with group member Genentech Roche, to develop, manufacture and market novel Navacim ™ therapeutic products for […]

Adaptive Biotechnologies to enter into a worldwide collaboration and license agreement with Genentech to develop personalized cell therapies for the treatment of cancer

SEATTLE – (COMMERCIAL THREAD) – Adaptive Biotechnologies, an immunological medicine company, today announced that it will enter into a worldwide collaboration and license agreement with Genentech, a member of the Roche Group, to develop, manufacture and commercialize novel cell-based therapies T directed by neoantigens for the treatment of a wide range of cancers. The collaboration […]

Back To Top